{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "c5c734a6-922b-4782-b7fd-edfdd01d8267",
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ADMET Predictions:\n",
      "{\n",
      "  \"AMES\": 0.05085576251149178,\n",
      "  \"AMES_drugbank_approved_percentile\": 19.852656068243505,\n",
      "  \"BBB_Martins\": 0.8109905123710632,\n",
      "  \"BBB_Martins_drugbank_approved_percentile\": 56.88251260178364,\n",
      "  \"Bioavailability_Ma\": 0.8728528261184693,\n",
      "  \"Bioavailability_Ma_drugbank_approved_percentile\": 65.8006979449399,\n",
      "  \"CYP1A2_Veith\": 0.015933018270879985,\n",
      "  \"CYP1A2_Veith_drugbank_approved_percentile\": 38.58084528887166,\n",
      "  \"CYP2C19_Veith\": 0.012031710240989923,\n",
      "  \"CYP2C19_Veith_drugbank_approved_percentile\": 18.37921675067856,\n",
      "  \"CYP2C9_Substrate_CarbonMangels\": 0.3684398144483566,\n",
      "  \"CYP2C9_Substrate_CarbonMangels_drugbank_approved_percentile\": 85.14928266770066,\n",
      "  \"CYP2C9_Veith\": 0.031664181500673294,\n",
      "  \"CYP2C9_Veith_drugbank_approved_percentile\": 47.576580069794495,\n",
      "  \"CYP2D6_Substrate_CarbonMangels\": 0.0254895331338048,\n",
      "  \"CYP2D6_Substrate_CarbonMangels_drugbank_approved_percentile\": 18.573090345094997,\n",
      "  \"CYP2D6_Veith\": 0.006942124478518963,\n",
      "  \"CYP2D6_Veith_drugbank_approved_percentile\": 20.589375727025978,\n",
      "  \"CYP3A4_Substrate_CarbonMangels\": 0.09314110800623894,\n",
      "  \"CYP3A4_Substrate_CarbonMangels_drugbank_approved_percentile\": 8.918185343156262,\n",
      "  \"CYP3A4_Veith\": 0.00023585804883623495,\n",
      "  \"CYP3A4_Veith_drugbank_approved_percentile\": 11.554866227219852,\n",
      "  \"Caco2_Wang\": -4.406400482370849,\n",
      "  \"Caco2_Wang_drugbank_approved_percentile\": 86.35129895308259,\n",
      "  \"Carcinogens_Lagunin\": 0.2533529222011566,\n",
      "  \"Carcinogens_Lagunin_drugbank_approved_percentile\": 66.65374176037224,\n",
      "  \"Clearance_Hepatocyte_AZ\": 22.27286196674449,\n",
      "  \"Clearance_Hepatocyte_AZ_drugbank_approved_percentile\": 35.09112058937573,\n",
      "  \"Clearance_Microsome_AZ\": 29.698106258353015,\n",
      "  \"Clearance_Microsome_AZ_drugbank_approved_percentile\": 61.768127181077936,\n",
      "  \"ClinTox\": 0.13706256486475468,\n",
      "  \"ClinTox_drugbank_approved_percentile\": 58.12330360604886,\n",
      "  \"DILI\": 0.8547624707221985,\n",
      "  \"DILI_drugbank_approved_percentile\": 76.5412950756107,\n",
      "  \"HIA_Hou\": 0.9971104025840759,\n",
      "  \"HIA_Hou_drugbank_approved_percentile\": 54.207056998836755,\n",
      "  \"Half_Life_Obach\": 3.5387631247176308,\n",
      "  \"Half_Life_Obach_drugbank_approved_percentile\": 43.42768514928267,\n",
      "  \"HydrationFreeEnergy_FreeSolv\": -8.788301226773218,\n",
      "  \"HydrationFreeEnergy_FreeSolv_drugbank_approved_percentile\": 58.6273749515316,\n",
      "  \"LD50_Zhu\": 2.214422730633969,\n",
      "  \"LD50_Zhu_drugbank_approved_percentile\": 30.825901512214035,\n",
      "  \"Lipinski\": 4.0,\n",
      "  \"Lipinski_drugbank_approved_percentile\": 63.80379992245056,\n",
      "  \"Lipophilicity_AstraZeneca\": -1.6280063302730858,\n",
      "  \"Lipophilicity_AstraZeneca_drugbank_approved_percentile\": 7.5610701822411785,\n",
      "  \"NR-AR\": 0.02305667195469141,\n",
      "  \"NR-AR-LBD\": 0.002197451703250408,\n",
      "  \"NR-AR-LBD_drugbank_approved_percentile\": 17.72004652966266,\n",
      "  \"NR-AR_drugbank_approved_percentile\": 49.12756882512602,\n",
      "  \"NR-AhR\": 0.007421723892912268,\n",
      "  \"NR-AhR_drugbank_approved_percentile\": 31.17487398216363,\n",
      "  \"NR-Aromatase\": 0.0006330780102871359,\n",
      "  \"NR-Aromatase_drugbank_approved_percentile\": 12.291585886002327,\n",
      "  \"NR-ER\": 0.029106757789850234,\n",
      "  \"NR-ER-LBD\": 0.003623103746213019,\n",
      "  \"NR-ER-LBD_drugbank_approved_percentile\": 16.789453276463746,\n",
      "  \"NR-ER_drugbank_approved_percentile\": 11.709965102753005,\n",
      "  \"NR-PPAR-gamma\": 0.004367552604526282,\n",
      "  \"NR-PPAR-gamma_drugbank_approved_percentile\": 48.5459480418767,\n",
      "  \"PAMPA_NCATS\": 0.2673666700720787,\n",
      "  \"PAMPA_NCATS_drugbank_approved_percentile\": 24.27297402093835,\n",
      "  \"PPBR_AZ\": 73.18028435667074,\n",
      "  \"PPBR_AZ_drugbank_approved_percentile\": 47.34393175649476,\n",
      "  \"Pgp_Broccatelli\": 0.00825292665977031,\n",
      "  \"Pgp_Broccatelli_drugbank_approved_percentile\": 20.628150445909267,\n",
      "  \"QED\": 0.5501217966938848,\n",
      "  \"QED_drugbank_approved_percentile\": 54.47848003101977,\n",
      "  \"SR-ARE\": 0.00882871700450778,\n",
      "  \"SR-ARE_drugbank_approved_percentile\": 8.375339278790229,\n",
      "  \"SR-ATAD5\": 0.0012725535430945455,\n",
      "  \"SR-ATAD5_drugbank_approved_percentile\": 26.754556029468787,\n",
      "  \"SR-HSE\": 0.006973763043060899,\n",
      "  \"SR-HSE_drugbank_approved_percentile\": 36.952307095773556,\n",
      "  \"SR-MMP\": 0.0017703489284031093,\n",
      "  \"SR-MMP_drugbank_approved_percentile\": 17.215975184179914,\n",
      "  \"SR-p53\": 0.001996007177513093,\n",
      "  \"SR-p53_drugbank_approved_percentile\": 18.650639782861575,\n",
      "  \"Skin_Reaction\": 0.3067779213190079,\n",
      "  \"Skin_Reaction_drugbank_approved_percentile\": 35.98293912369135,\n",
      "  \"Solubility_AqSolDB\": -1.4189942750609603,\n",
      "  \"Solubility_AqSolDB_drugbank_approved_percentile\": 77.27801473439317,\n",
      "  \"VDss_Lombardo\": 6.688882144785967,\n",
      "  \"VDss_Lombardo_drugbank_approved_percentile\": 82.78402481582009,\n",
      "  \"hERG\": 0.0033732878742739557,\n",
      "  \"hERG_drugbank_approved_percentile\": 3.179526948429624,\n",
      "  \"hydrogen_bond_acceptors\": 3.0,\n",
      "  \"hydrogen_bond_acceptors_drugbank_approved_percentile\": 31.17487398216363,\n",
      "  \"hydrogen_bond_donors\": 1.0,\n",
      "  \"hydrogen_bond_donors_drugbank_approved_percentile\": 36.68088406359054,\n",
      "  \"logP\": 1.3101,\n",
      "  \"logP_drugbank_approved_percentile\": 36.25436215587437,\n",
      "  \"molecular_weight\": 180.15899999999996,\n",
      "  \"molecular_weight_drugbank_approved_percentile\": 14.307871267933308,\n",
      "  \"stereo_centers\": 0.0,\n",
      "  \"stereo_centers_drugbank_approved_percentile\": 22.489336952307095,\n",
      "  \"tpsa\": 63.60000000000001,\n",
      "  \"tpsa_drugbank_approved_percentile\": 41.74098487785963\n",
      "}\n",
      "\n",
      "AI Analysis:\n",
      "The SMILES string CC(=O)OC1=CC=CC=C1C(=O)O represents acetylsalicylic acid (aspirin).  Let's analyze its properties:\n",
      "\n",
      "\n",
      "**1. Drug-likeness:**\n",
      "\n",
      "* **Molecular Weight:** 180.16 g/mol is well within the acceptable range for drug-likeness (generally <500 g/mol).\n",
      "* **logP:** 1.31 is relatively low, indicating good water solubility.  This is favorable for drug absorption and distribution.  While slightly lipophilic, it's not excessively so.\n",
      "* **TPSA (Topological Polar Surface Area):** 63.6 Å² is moderate.  This suggests reasonable interaction with biological targets and acceptable permeability.\n",
      "\n",
      "Overall, aspirin shows good drug-likeness based on these parameters.  Its long history of safe and effective use further supports this.\n",
      "\n",
      "\n",
      "**2. Potential Risks:**\n",
      "\n",
      "* **Gastrointestinal irritation:** Aspirin is a well-known irritant to the stomach lining, leading to potential bleeding and ulcers. This is a significant risk, particularly at higher doses or with prolonged use.\n",
      "* **Allergic reactions:**  Aspirin allergy is a serious concern and can manifest in various ways, from mild skin reactions to life-threatening anaphylaxis.\n",
      "* **Reye's syndrome:**  Aspirin should not be given to children or teenagers with viral infections due to the risk of Reye's syndrome, a rare but potentially fatal condition.\n",
      "* **Bleeding:** Aspirin inhibits platelet aggregation, increasing bleeding risk. This is particularly relevant for individuals with bleeding disorders or those undergoing surgery.\n",
      "* **Drug interactions:** Aspirin can interact with other medications, particularly anticoagulants and some nonsteroidal anti-inflammatory drugs (NSAIDs).\n",
      "\n",
      "\n",
      "**3. Overall Assessment:**\n",
      "\n",
      "Aspirin (acetylsalicylic acid) is a well-established drug with excellent drug-likeness properties based on its molecular weight, logP, and TPSA.  However, it carries significant potential risks, primarily related to gastrointestinal irritation, allergic reactions, and bleeding.  Its use requires careful consideration of these risks and potential drug interactions, particularly in specific populations (children, individuals with bleeding disorders, etc.).  The benefits of aspirin's analgesic, anti-inflammatory, and antiplatelet effects must be carefully weighed against these known risks before administration.  Despite its risks, its efficacy and long history of safe use (when used appropriately) make it a valuable medication.\n",
      "\n",
      "\n",
      "Molecule Image:\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import requests\n",
    "import json\n",
    "from IPython.display import Image, display\n",
    "\n",
    "# Define the API endpoint\n",
    "url = \"http://localhost:5000/analyze\"\n",
    "\n",
    "# Test data\n",
    "test_data = {\n",
    "    \"smiles\": \"CC(=O)OC1=CC=CC=C1C(=O)O\"  # Aspirin\n",
    "}\n",
    "\n",
    "# Make a POST request to the API\n",
    "response = requests.post(url, json=test_data)\n",
    "\n",
    "# Check the response\n",
    "if response.status_code == 200:\n",
    "    result = response.json()\n",
    "    print(\"ADMET Predictions:\")\n",
    "    print(json.dumps(result['predictions'], indent=2))\n",
    "\n",
    "    print(\"\\nAI Analysis:\")\n",
    "    print(result['analysis'])\n",
    "\n",
    "    # Display the molecule image\n",
    "    if result.get('image_path'):\n",
    "        print(\"\\nMolecule Image:\")\n",
    "        display(Image(filename=result['image_path']))\n",
    "else:\n",
    "    print(f\"Error: {response.status_code}\")\n",
    "    print(response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e447b39c-6f92-47be-b4d7-0058a6fb927c",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "environment": {
   "kernel": "conda-base-py",
   "name": "workbench-notebooks.m126",
   "type": "gcloud",
   "uri": "us-docker.pkg.dev/deeplearning-platform-release/gcr.io/workbench-notebooks:m126"
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel) (Local)",
   "language": "python",
   "name": "conda-base-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.15"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
